Semanteon Capital Management LP Purchases Shares of 7,101 The Cooper Companies, Inc. (NASDAQ:COO)

Semanteon Capital Management LP acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 7,101 shares of the medical device company's stock, valued at approximately $784,000.

Several other institutional investors and hedge funds have also made changes to their positions in COO. Vanguard Group Inc. boosted its holdings in Cooper Companies by 303.0% during the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company's stock worth $2,343,723,000 after buying an additional 17,367,502 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC grew its position in Cooper Companies by 3.0% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 7,820,590 shares of the medical device company's stock worth $682,738,000 after purchasing an additional 231,155 shares in the last quarter. Capital World Investors grew its position in Cooper Companies by 301.7% during the 1st quarter. Capital World Investors now owns 5,654,023 shares of the medical device company's stock worth $573,657,000 after purchasing an additional 4,246,519 shares in the last quarter. Janus Henderson Group PLC grew its position in Cooper Companies by 279.8% during the 1st quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company's stock worth $348,723,000 after purchasing an additional 2,532,186 shares in the last quarter. Finally, Impax Asset Management Group plc grew its position in Cooper Companies by 31.0% during the 2nd quarter. Impax Asset Management Group plc now owns 2,359,798 shares of the medical device company's stock worth $205,511,000 after purchasing an additional 558,886 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

COO has been the topic of several research analyst reports. Piper Sandler lifted their price objective on shares of Cooper Companies from $115.00 to $120.00 and gave the stock an "overweight" rating in a research report on Thursday, August 29th. Jefferies Financial Group upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $107.00 to $115.00 in a research report on Tuesday, July 16th. Wells Fargo & Company lifted their price objective on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an "overweight" rating in a research report on Thursday, August 29th. Robert W. Baird lifted their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the company an "outperform" rating in a research note on Thursday, August 29th. Finally, Morgan Stanley lifted their target price on shares of Cooper Companies from $95.00 to $104.00 and gave the company an "equal weight" rating in a research note on Tuesday, September 10th. Three research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $115.00.

Insiders Place Their Bets

In other news, CEO Albert G. White III sold 114,992 shares of the business's stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the transaction, the chief executive officer now owns 165,273 shares in the company, valued at approximately $18,267,624.69. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, CFO Brian G. Andrews sold 24,788 shares of the business's stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the transaction, the chief financial officer now owns 6,614 shares in the company, valued at approximately $700,422.60. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Albert G. White III sold 114,992 shares of the business's stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the transaction, the chief executive officer now owns 165,273 shares in the company, valued at approximately $18,267,624.69. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 256,373 shares of company stock valued at $27,637,427 in the last quarter. Insiders own 2.00% of the company's stock.

Cooper Companies Stock Down 2.1 %

Shares of COO stock traded down $2.31 on Monday, hitting $105.51. The company's stock had a trading volume of 950,909 shares, compared to its average volume of 1,127,375. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18. The Cooper Companies, Inc. has a fifty-two week low of $75.93 and a fifty-two week high of $112.38. The firm's fifty day moving average price is $105.94 and its 200-day moving average price is $96.77. The stock has a market capitalization of $21.01 billion, a price-to-earnings ratio of 58.78, a P/E/G ratio of 2.53 and a beta of 0.98.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts' consensus estimates of $0.91 by $0.05. The firm had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business's revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.84 EPS. Research analysts anticipate that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.